Copertina

Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation

Salvato in:
Pubblicato in:Pharmaceuticals vol. 18, no. 8 (2025), p. 1157-1189
Autore principale: Niazi, Sarfaraz K
Pubblicazione:
MDPI AG
Soggetti:
Food & Drug Administration > FDA
United States > US
Germany
Monoclonal antibodies
Product quality
Collaboration
Real time
Batch processes
Process controls
Biological products
Pharmaceutical industry
Capital expenditures
Batch processing
Manufacturing
Cost control
19th century
Product testing
Accesso online:Citation/Abstract
Full Text + Graphics
Full Text - PDF
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
Lascia un commento!
Entra